# OSTEOCALCIN FUNCTION IN RESORPTION

> **NIH NIH R01** · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 1993 · $182,627

## Abstract

The bone vitamin K dependent protein, osteocalcin, is an osteoblast specific
product with specialized calcium binding properties to hydroxyapatite.  Its
measurement in the circulation is widely used as a non-invasive parameter of
bone turnover, yet its precise function remains elusive.  We have evidence
to postulate a role for osteocalcin in mediating osteoclast differentiation
and activation in several in vivo and in vitro model systems developed for
the study of bone resorption.  We have also shown osteocalcin can directly
promote fusion of progenitor cells into multinucleated tartrate resistant
acid phosphatase positive (TRAP) cells that develop a ruffle border
membranes, characteristic features of osteoclasts.  Our long range goal is
to define the precise mechanism by which osteocalcin participates in the
regulated resorption of bone mineral.  In the current proposal our efforts
are initially to define the specificity of osteocalcin in the early stages
of recruitment of progenitor cells and their fusion to multinucleated
activated osteoclasts using the in vivo implant system and in vitro culture
studies with bone marrow progenitor cells.  Secondly we will define specific
regions of the osteocalcin molecule that are requisite for promoting
osteoclast differentiation site directed mutagenesis of the rat osteocalcin
gene.  Those amino acid which participate in presumed function and precise
structural folding of the molecule when associated with hydroxyapatite
crystals will be altered and the molecules tested in the in vivo implant
model and in vitro bone marrow cultures.  Thirdly the molecular defect
associated with osteocalcin-deplete bone in osteoclast differentiation will
be identified by, +/- and subtractive hybridization screening of cDNA
libraries generated from functional osteoclast generated to normal bone
particles and to the multinucleated cell surrounding osteocalcin-deplete
bone implants.  We will characterize the genes expressed during osteoclast
differentiation that are mediated by osteocalcin.  These proposed studies
will define a molecular role for osteocalcin in the differentiation of
progenitor cells to a fully functioning osteoclast and in doing so we will
better understand control mechanisms of normal bone resorption by bone
matrix components.  Knowledge of the structure function relationships of the
osteocalcin molecule to induction of osteoclast differentiation and bone
resorption could provide a rationale for therapeutic intervention of bone
resorption osteoporosis and in diseases associated with high bone turnover.

## Key facts

- **NIH application ID:** 3157071
- **Project number:** 5R01AR035166-08
- **Recipient organization:** UNIV OF MASSACHUSETTS MED SCH WORCESTER
- **SAM.gov UEI:** MQE2JHHJW9Q8
- **Principal Investigator:** Jane B. Lian
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 1993
- **Award amount:** $182,627
- **Award type:** 5
- **Project period:** 1989-02-01 → 1994-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/3157071

## Citation

> US National Institutes of Health, RePORTER application 3157071, OSTEOCALCIN FUNCTION IN RESORPTION (5R01AR035166-08). Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/grant/nih/3157071. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
